Anesta Corp. is engaged in the development of pharmaceutical products for oral transmucosal drug administration. The company's product, Actiq®, approved by the U.S. Food and Drug Administration, was designed for breakthrough cancer pain. As of October 10, 2000, Anesta Corp. operates as a subsidiary of Cephalon Inc.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.